Trial Profile
Pharmacokinetic Study of Modified Release Formulations and an Immediate Release Formulation of ORM-12741 After Single Oral Doses
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 May 2015
Price :
$35
*
At a glance
- Drugs ORM 12741 (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Acronyms Nebula PK 1
- Sponsors Orion
- 05 May 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 23 Dec 2014 New trial record